Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Eichhorst
B
B
Department of Internal Medicine I, University of Köln, Germany.
Hallek
M
M
Dreyling
M
M
D018941:Antigens, CD19 / Q000378:metabolism; D018951:Antigens, CD20 / Q000378:metabolism; D018956:CD5 Antigens / Q000378:metabolism; D004358:Drug Therapy; D005060:Europe / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D007167:Immunotherapy; D017404:In Situ Hybridization, Fluorescence; D015994:Incidence; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D011379:Prognosis; D017455:Receptors, IgE / Q000378:metabolism; D018570:Risk Assessment; D055502:Secondary Prevention; D033581:Stem Cell Transplantation; D016896:Treatment Outcome
D018941:Antigens, CD19; D018951:Antigens, CD20; D018956:CD5 Antigens; D017455:Receptors, IgE